Supplementation With EPA and DHA Associated With Reduced Risk of Cardiovascular Events
A new analysis of randomized control trials has found that supplementation with omega-3 fatty acids EPA and DHA may help reduce the risk of cardiovascular events. It also suggests that higher doses may be more effective.
For their analysis, the researchers looked at 40 studies that included 135,267 participants. The studies examined the association between supplementation with EPA and DHA and cardiovascular events including heart attack, coronary artery disease, and heart failure.
The researchers found that supplementation with EPA and DHA is associated with a 13% reduced risk of heart attack, a 10% reduced risk of coronary heart disease, and a 35% reduced risk of a fatal heart attack. It was also associated with a 9% reduced risk of coronary heart disease mortality. They also found that the optimal daily intake is between 800 and 1,200 mg per day.
The study was conducted by researchers from the University of Idaho, the University of Queensland School of Medicine, and the University of Eastern Finland. It was published online ahead of print on September 17, 2020 in the journal Mayo Clinic Proceedings.